A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine

Enhancing Rangatahi Wellbeing in Secondary Education Through Implementation of the Meke Meter™.

New Zealand journal of educational studies·2025

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.

Diabetes technology & therapeutics·2017

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

Current diabetes reports·2016

PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALS.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2015

Misled by the Morning "Fasting" Plasma Glucose.

Journal of diabetes science and technology·2015

Omitting late-night eating may cause hypoglycemia in "well controlled" basal insulin-treated type 2 diabetes.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2014

The Transition of Youth With Diabetes From Pediatric to Adult Diabetes Care Services: A Consensus Report of the Joint Working Group of the International Society for Pediatric and Adolescent Diabetes (ISPAD), the European Association for the Study of Diabetes (EASD), and the American Diabetes Association (ADA).

Diabetes care·2026

Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory).

Diabetes care·2026

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

Diabetes care·2026

β-Cell Dysfunction Identifies Individuals With Single Autoantibody Positivity at Increased Risk of Type 1 Diabetes Progression.

Diabetes care·2026

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists.

Diabetes care·2026

The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes.

Diabetes care·2026

Association of interleukin-6 rs1800796 polymorphism with keloid susceptibility and severity in a Vietnamese population: a case-control study.

Dermatology reports·2026

Immunochemical Characteristics of Half-Molecule IgG Presumed to Lack the CH2 Domain.

Clinical laboratory·2026

Tarlatamab in Relapsed SCLC With Idiopathic Pulmonary Fibrosis: A Case With Comparative DLL3 Expression Analysis: Case Report.

JTO clinical and research reports·2026

ITGBL1 and RPN1 Mark a Fibrotic NP Subpopulation with Coupled Integrin Signaling and N-Glycosylation Programs in IVDD.

Journal of inflammation research·2026

Hepatic mesenchymal hamartoma showing hepatobiliary-phase signal increase on gadoxetate disodium-enhanced magnetic resonance imaging: A case report.

Radiology case reports·2026

Comparative evaluation of parasitological, serological, and molecular methods for the diagnosis of cutaneous leishmaniasis in the Garmian area, Kurdistan region of Iraq.

Parasite epidemiology and control·2026

Related Experiment Videos

A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine

Related Concept Videos

Enhancing Rangatahi Wellbeing in Secondary Education Through Implementation of the Meke Meter™.

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALS.

Misled by the Morning "Fasting" Plasma Glucose.

Omitting late-night eating may cause hypoglycemia in "well controlled" basal insulin-treated type 2 diabetes.

Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory).

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

β-Cell Dysfunction Identifies Individuals With Single Autoantibody Positivity at Increased Risk of Type 1 Diabetes Progression.

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists.

The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes.

Association of interleukin-6 rs1800796 polymorphism with keloid susceptibility and severity in a Vietnamese population: a case-control study.

Immunochemical Characteristics of Half-Molecule IgG Presumed to Lack the CH2 Domain.

Tarlatamab in Relapsed SCLC With Idiopathic Pulmonary Fibrosis: A Case With Comparative DLL3 Expression Analysis: Case Report.

ITGBL1 and RPN1 Mark a Fibrotic NP Subpopulation with Coupled Integrin Signaling and N-Glycosylation Programs in IVDD.

Hepatic mesenchymal hamartoma showing hepatobiliary-phase signal increase on gadoxetate disodium-enhanced magnetic resonance imaging: A case report.

Comparative evaluation of parasitological, serological, and molecular methods for the diagnosis of cutaneous leishmaniasis in the Garmian area, Kurdistan region of Iraq.

Related Experiment Videos

A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine

Related Concept Videos

Related Articles